Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 1,100 | 1,260 | 1,850 | 1,600 | 2,200 |
| Cost of Goods | 110 | 120 | 130 | 90 | 240 |
| Gross Profit | 990 | 1,140 | 1,720 | 1,500 | 1,950 |
| Operating Expenses | 1,250 | 1,740 | 1,830 | 1,900 | 1,830 |
| Operating Income | -150 | -480 | 20 | -300 | 370 |
| Interest Expense | 10 | 10 | 10 | 10 | 30 |
| Other Income | 10 | 0 | 0 | 70 | 50 |
| Pre-tax Income | -150 | -490 | 10 | -240 | 390 |
| Income Tax | 0 | 5 | -6 | -2 | 10 |
| Net Income Continuous | -150 | -495 | 16 | -238 | 380 |
| Net Income | $-150 | $-490 | $10 | $-240 | $380 |
| EPS Basic Total Ops | -50,569.55 | -163,756.70 | 3,342.00 | -106,252.40 | 249,140.20 |
| EPS Basic Continuous Ops | -50,569.55 | -165,427.70 | 5,347.20 | -105,367.00 | 249,140.20 |
| EBITDA(a) | $-100 | $-400 | $120 | $-170 | $450 |